Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

PSAT1 Polyclonal antibody

PSAT1 Polyclonal Antibody for WB, IHC, IF/ICC, FC (Intra), IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, FC (Intra), IP, ELISA

EC:2.6.1.52, EPIP, Phosphoserine aminotransferase, PSA, PSAT

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for PSAT1 in ?

Tested Applications

Positive WB detected inHeLa cells, HEK-293 cells, A549 cells, K-562 cells, mouse brain tissue, rat brain tissue
Positive IP detected inHeLa cells
Positive IHC detected inhuman lung cancer tissue, human breast cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells
Positive FC (Intra) detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:8000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

20180-1-AP targets PSAT1 in WB, IHC, IF/ICC, FC (Intra), IP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag14044

Product name: Recombinant human PSAT1 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-370 aa of BC001618

Sequence: MDAPRQVVNFGPGPAKLPHSVLLEIQKELLDYKGVGISVLEMSHRSSDFAKIINNTENLVRELLAVPDNYKVIFLQGGGCGQFSAVPLNLIGLKAGRCADYVVTGAWSAKAAEEAKKFGTINIVHPKLGSYTKIPDPSTWNLNPDASYVYYCANETVHGVEFDFIPDVKGAVLVCDMSSNFLSKPVDVSKFGVIFAGAQKNVGSAGVTVVIVRDDLLGFALRECPSVLEYKVQAGNSSLYNTPPCFSIYVMGLVLEWIKNNGGAAAMEKLSSIKSQTIYEIIDNSQGFYVCPVEPQNRSKMNIPFRIGNAKGDDALEKRFLDKALELNMLSLKGHRSVGGIRASLYNAVTIEDVQKLAAFMKKFLEMHQL

Predict reactive species
Full Name phosphoserine aminotransferase 1
Calculated Molecular Weight 370 aa, 40 kDa
Observed Molecular Weight 37-40 kDa
GenBank Accession NumberBC001618
Gene Symbol PSAT1
Gene ID (NCBI) 29968
RRIDAB_10665948
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9Y617
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

PSAT1, also named as PSA and PSAT, belongs to the class-V pyridoxal-phosphate-dependent aminotransferase family and SerC subfamily. It catalyzes the reversible conversion of 3-phosphohydroxypyruvate to phosphoserine and of 3-hydroxy-2-oxo-4-phosphonooxybutanoate to phosphohydroxythreonine. PSAT1 represents a new interesting target for CRC therapy. (PMID:18221502) It may be implicated in altered serine metabolism and schizophrenia spectrum conditions. (PMID:20955740 )

Protocols

Product Specific Protocols
FC protocol for PSAT1 antibody 20180-1-APDownload protocol
IF protocol for PSAT1 antibody 20180-1-APDownload protocol
IHC protocol for PSAT1 antibody 20180-1-APDownload protocol
IP protocol for PSAT1 antibody 20180-1-APDownload protocol
WB protocol for PSAT1 antibody 20180-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The PSAT1 antibody (Cat# 20180-1-AP) has 14 total citations spanning high-impact journals including Nature, Science, Nat Metab, Cancer Res, PNAS, EMBO Mol Med, EMBO Rep, eLife, Autophagy, Mol Metab, Br J Cancer, J Transl Med, Front Immunol, and BMC Cancer. Research fields center on serine biosynthesis, mTOR/ATF4 signaling, one-carbon metabolism, cancer metabolic reprogramming, autophagy, and tumor immune evasion in prostate, breast, gastric, lung, colorectal, and renal cancers.

SpeciesApplicationTitle

Nature

Ageing promotes metastasis via activation of the integrated stress response

Authors - Angana A H Patel

Science

mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle.

Authors - Issam Ben-Sahra
humanWB

Nat Metab

Identifying strategies to target the metabolic flexibility of tumours.

Authors - Andrés Méndez-Lucas
humanWB

Cancer Res

Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer

Authors - Young A Yoo
mouseWB

Autophagy

Autophagy dictates PHGDH-mediated serine metabolism in a timely manner to support oocyte development.

Authors - Hainan He
  • KD Validated
humanIHC

J Transl Med

SNHG12 drives gastric cancer progression by activating the Wnt/β-catenin-mediated serine synthesis pathway.

Authors - Nianjie Zhang
Loading...
||
New chat

Able™

正在加载,请稍候...